- Agoro R, White KE. Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions. Nat Rev Nephrol. 2023 Mar; 19(3):185-193
- Agoro R, Nookaew I, Noonan ML, Marambio YG, Liu S, Chang W, Gao H, Hibbard LM, Metzger CE, Horan D, Thompson WR, Xuei X, Liu Y, Zhang C, Robling AG, Bonewald LF, Wan J, White KE. Single cell cortical bone transcriptomics define novel osteolineage gene sets altered in chronic kidney disease. Front Endocrinol (Lausanne). 2023; 14:1063083
- Noonan ML, Ni P, Solis E, Marambio YG, Agoro R, Chu X, Wang Y, Gao H, Xuei X, Clinkenbeard EL, Jiang G, Liu S, Stegen S, Carmeliet G, Thompson WR, Liu Y, Wan J, White KE. Osteocyte Egln1/Phd2 links oxygen sensing and biomineralization via FGF23. Bone Res. 2023 Jan 18; 11(1):7
- Agoro R, White KE. Anemia and fibroblast growth factor 23 elevation in chronic kidney disease: homeostatic interactions and emerging therapeutics. Curr Opin Nephrol Hypertens. 2022 Jul 1; 31(4):320-325
- Liesen MP, Noonan ML, Ni P, Agoro R, Hum JM, Clinkenbeard EL, Damrath JG, Wallace JM, Swallow EA, Allen MR, White KE. Segregating the effects of ferric citrate-mediated iron utilization and FGF23 in a mouse model of CKD. Physiol Rep. 2022 Jun; 10(11):e15307
- Noonan ML, Ni P, Agoro R, Sacks SA, Swallow EA, Wheeler JA, Clinkenbeard EL, Capitano ML, Prideaux M, Atkins GJ, Thompson WR, Allen MR, Broxmeyer HE, White KE. The HIF-PHI BAY 85-3934 (Molidustat) Improves Anemia and Is Associated With Reduced Levels of Circulating FGF23 in a CKD Mouse Model. J Bone Miner Res. 2021 Jun; 36(6):1117-1130
- Agoro R, Park MY, Le Henaff C, Jankauskas S, Gaias A, Chen G, Mohammadi M, Sitara D. C-FGF23 peptide alleviates hypoferremia during acute inflammation. Haematologica. 2021 Feb 1; 106(2):391-403
- Agrawal A, Ni P, Agoro R, White KE, DiMarchi RD. Identification of a second Klotho interaction site in the C terminus of FGF23. Cell Rep. 2021 Jan 26; 34(4):108665
- Agoro R. In the COVID-19 era, let’s keep an eye on clinical trials in Africa. J Glob Health. 2020 Dec; 10(2):020312
- Agoro R, Ni P, Noonan ML, White KE. Osteocytic FGF23 and Its Kidney Function. Front Endocrinol (Lausanne). 2020; 11:592
- Agoro R. How African scientists can give back to their home continent. Nature. 2020 Jul 31
- Noonan ML, Clinkenbeard EL, Ni P, Swallow EA, Tippen SP, Agoro R, Allen MR, White KE. Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD). Physiol Rep. 2020 Jun; 8(11):e14434
Full List of Publications
